The DIAPHRAGM study: Diagnostic and prognostic biomarkers in the rational assessment of Mesothelioma

被引：1
|
作者：
Tsim, Selina [1 ]
Kelly, Caroline [2 ]
Alexander, Laura [2 ]
Shaw, Ann [2 ]
Paul, James [2 ]
Woodward, Rosemary [1 ]
Foster, John [1 ]
Blyth, Kevin [1 ]
机构：
[1] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland
[2] CRUK Clin Trials Unit, Glasgow, Lanark, Scotland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.OA493
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA493
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preliminary Results of the Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) Study
    Tsim, S.
    Kelly, C.
    Alexander, L.
    Evison, M.
    Holme, J.
    Cameron, E. J.
    Wright, A.
    Grundy, S.
    Grieve, D.
    Ionescu, A.
    Breen, D.
    Paramasivan, E.
    Psallidas, I.
    McCormick, C.
    Thomson, F.
    Ostroff, R.
    Maskell, N.
    Blyth, K. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Preliminary results of the Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study
    Tsim, S.
    Kelly, C.
    Evison, M.
    Cameron, E.
    Wright, A.
    Grundy, S.
    Grieve, D.
    Ionescu, A.
    Breen, D.
    Holme, J.
    Paramasivamu, E.
    Psallidas, I.
    McCormick, C.
    Thomson, F.
    Alexander, L.
    Ostroff, R.
    Maskell, N.
    Blyth, K. G.
    LUNG CANCER, 2018, 115 : S29 - S30
  • [3] Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study
    Tsim, Selina
    Kelly, Caroline
    Alexander, Laura
    McCormick, Carol
    Thomson, Fiona
    Woodward, Rosie
    Foster, John E.
    Stobo, David B.
    Paul, Jim
    Maskell, Nick A.
    Chalmers, Anthony
    Blyth, Kevin G.
    BMJ OPEN, 2016, 6 (11):
  • [4] Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
    Chen, Zhongjian
    Gaudino, Giovanni
    Pass, Harvey I.
    Carbone, Michele
    Yang, Haining
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (03) : 259 - 269
  • [5] Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers
    Creaney, Jenette
    Dick, Ian M.
    Musk, A. W.
    Olsen, Nola J.
    Robinson, Bruce W. S.
    BIOMARKERS, 2016, 21 (06) : 551 - 561
  • [6] Biomarkers and prognostic factors for mesothelioma
    Pass, Harvey I.
    ANNALS OF CARDIOTHORACIC SURGERY, 2012, 1 (04) : 449 - 456
  • [7] (Debate on) Prognostic Biomarkers in Mesothelioma
    Robinson, Bruce W. S.
    Creaney, Jeanette
    Dick, Ian M.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S159 - S160
  • [8] PROGNOSTIC BIOMARKERS IN MALIGNANT PLEURAL MESOTHELIOMA
    Mezzapelle, R.
    Miglio, U.
    Rena, O.
    Mercalli, F.
    Veggiani, C.
    Paganotti, A.
    Buosi, R.
    Rinaldi, M.
    Boldorini, R.
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide
    Dipalma, Nicola
    Luisi, Vito
    Di Serio, Francesca
    Fontana, Antonietta
    Maggiolini, Piera
    Licchelli, Brunella
    Mera, Ernesto
    Bisceglia, Lucia
    Galise, Ida
    Loizzi, Michele
    Pizzigallo, Maria Annunziata
    Molinini, Raffaele
    Vimercati, Luigi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2011, 26 (03): : 160 - 165
  • [10] Diagnostic mesothelioma biomarkers in effusion cytology
    Eccher, Albino
    Girolami, Ilaria
    Lucenteforte, Ersilia
    Troncone, Giancarlo
    Scarpa, Aldo
    Pantanowitz, Liron
    CANCER CYTOPATHOLOGY, 2021, 129 (07) : 506 - 516
12345